Link to this page
PMO Precision Medicine Ontology
Last uploaded:
December 16, 2020
Jump to:
| Preferred Name | Bexarotene | |
| Synonyms |
|
|
| ID |
http://www.phoc.org.cn/pmo/class/PMO_00026196 |
|
| Database_Cross_Reference |
NCI_FDA:A61RXM4375 DRUGBANK:DB00307 SNOMEDCT_US:395281006 MSH:C095105 ATC:L01XX25 MMSL:234760 MMSL:d04507 NDDF:008004 NCI_NCI-GLOSS:CDR0000045423 MMSL:8604 USPMG:MTHU000528 SNOMEDCT_US:116346006 VANDF:4021197 MTHSPL:A61RXM4375 CHV:0000048632 NDFRT:N0000006359 SNOMEDCT_US:387023000 MEDCIN:191431 NCI_DCP:09151 NCI:C1635 PDQ:CDR0000042117 RXNORM:233272 NDFRT:N0000148643
|
|
| label |
Bexarotene
|
|
| MCID |
MC00263750
|
|
| PMOID |
PMO:00026196
|
|
| prefixIRI |
pmo:PMO_00026196
|
|
| prefLabel |
Bexarotene
|
|
| Synonym |
Bexaroteno bexarotene bexarotene [Chemical/Ingredient] retinoids bexarotene Bexarotenum Bexaroten 4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid BEXAROTENE 4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid Bexarotene (product) Bexarotène 4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl)benzoic acid 3-methyl-TTNEB Bexarotene (substance) bexarotene (medication) p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid 4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic Acid 3-methyl TTNEB
|
|
| Tree Number |
T6.4.4.1.2.17
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping